Evidence map›Paper›PMID 35613754›Full record

ArticleBMJ open2022

Association of subclinical atherosclerosis and cognitive decline: a community-based cross-sectional study.

Yao Lu, Yidan Zhu, Yanjun Ma, Chenglong Li, Rong Hua, Baoliang Zhong, Hongyu Wang, Wuxiang Xie

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yao LuPeking University Clinical Research Institute, Peking University First Hospital, Beijing, China.ORCID 0000-0001-6747-9210
Yidan ZhuPeking University Clinical Research Institute, Peking University First Hospital, Beijing, China.
Yanjun MaPeking University Clinical Research Institute, Peking University First Hospital, Beijing, China.
Chenglong LiPeking University Clinical Research Institute, Peking University First Hospital, Beijing, China.
Rong HuaPeking University Clinical Research Institute, Peking University First Hospital, Beijing, China.
Baoliang ZhongDepartment of Geriatric Psychiatry, Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science & Technology, Wuhan, China.
Hongyu WangPUCRI Heart and Vascular Health Research Center at Peking University Shougang Hospital, Beijing, China xiewuxiang@hsc.pku.edu.cn dr.hongyuwang@foxmail.com.
Wuxiang XiePeking University Clinical Research Institute, Peking University First Hospital, Beijing, China xiewuxiang@hsc.pku.edu.cn dr.hongyuwang@foxmail.com.ORCID 0000-0001-7527-1022
Peking University · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsGrowing burden of dementia was considered as a global public health priority as its epidemic scale rises with the world's population increases in age. In the absence of effective treatment, early identification of decline in cognitive function and risk factors that lead to the onset of dementia is a critical issue. Subclinical atherosclerosis may be a potential risk factor for cognitive impairment and progression to dementia. Research is needed to identify which subclinical atherosclerosis risk factors can better predict cognitive decline.

methodsA total of 1554 participants (mean age 59.81±6.93 years) were enrolled from Beijing Research on Ageing and Vessel and underwent baseline evaluation. Carotid intima-media thickness, carotid plaque and brachial ankle pulse wave velocity (ba-PWV) were selected as subclinical atherosclerosis markers. Cognitive function assessment was conducted by standardised tasks to assess the associations with subclinical atherosclerosis markers.

resultsSignificant associations (p<0.001) were shown in the unadjusted models between all three subclinical atherosclerosis markers and cognitive function assessments. After adjusting for covariates, in the assessment of the association between carotid atherosclerosis and cognitive function, plaque numbers showed significant associations in Montreal Cognitive Assessment (MoCA) (β=-0.15, p=0.006) and verbal memory scores (β=-0.13, p=0.013). While in the assessment of the association between arterial stiffness and cognitive function, ba-PWV showed significant associations in MoCA (β=-0.09, p=0.009) and semantic fluency scores (β=-0.13, p=0.036).

conclusionsPositive associations shown between subclinical atherosclerosis and cognitive function. Subclinical atherosclerosis markers of plaque numbers were significantly associated with global cognitive functioning in MoCA, memory and semantic fluency, while ba-PWV was significantly associated with global cognitive functioning in MoCA and semantic fluency.

Indexed as

AtherosclerosisCognitive DysfunctionDementiaPlaque, AtheroscleroticAgedAnkle Brachial IndexBiomarkersCarotid Intima-Media ThicknessCross-Sectional StudiesHumansMiddle AgedPulse Wave AnalysisRisk FactorsBiomarkersadult neurologydementiaparkinson-s disease

Identifiers

PMID35613754
PMCPMC9125759
OpenAlexW4281554499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.